Related references
Note: Only part of the references are listed.The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care
Juan Jesus Carrero et al.
JOURNAL OF INTERNAL MEDICINE (2022)
An introduction to inverse probability of treatment weighting in observational research
Nicholas C. Chesnaye et al.
CLINICAL KIDNEY JOURNAL (2022)
The Impairment in Kidney Function in the Oral Anticoagulation Era. A Pathophysiological Insight
Pietro Scicchitano et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treatead with Apixaban Versus Warfarin
James B. Wetmore et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them
Edouard L. Fu et al.
CLINICAL KIDNEY JOURNAL (2021)
Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrumof kidney function
Ype de Jong et al.
EUROPEAN HEART JOURNAL (2021)
The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation
Ziv Harel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants
Justin Ashley et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study
Daniele Pastori et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation
Xiaoxi Yao et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes
Adrian Hernandez et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2020)
Using All Longitudinal Data to Define Time to Specified Percentages of Estimated GFR Decline: A Simulation Study
Jarcy Zee et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Merits and caveats of propensity scores to adjust for confounding
Edouard L. Fu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Decreased risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants: A pooled analysis of randomized controlled trials and real-world studies
Chi Zhang et al.
THROMBOSIS RESEARCH (2019)
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease A Systematic Review and Meta-analysis
Jeffrey T. Ha et al.
ANNALS OF INTERNAL MEDICINE (2019)
The Role of Vitamin K in Vascular Calcification
Mario Cozzolino et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2019)
Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function
Masaki Ikeda et al.
CEN CASE REPORTS (2019)
Rivaroxaban's Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis
Craig I. Coleman et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2019)
Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
Tomas Forslund et al.
EUROPACE (2018)
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
Jung-Im Shin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Yi-Hsin Chan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy
Sergey V. Brodsky et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2017)
Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases
Leonard Golbin et al.
CLINICAL KIDNEY JOURNAL (2017)
Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants
Christina L. Fanola et al.
AMERICAN HEART JOURNAL (2017)
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin Insights From ROCKET AF
Christopher B. Fordyce et al.
CIRCULATION (2016)
Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin
Yi-Hsin Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
Martin J. O'Donnell et al.
LANCET (2016)
Prevalence and recognition of chronic kidney disease in Stockholm healthcare
Alessandro Gasparini et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time Insights From the ARISTOTLE Randomized Clinical Trial
Ziad Hijazi et al.
JAMA CARDIOLOGY (2016)
The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
Bjorn Runesson et al.
CLINICAL KIDNEY JOURNAL (2016)
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbuchel et al.
EUROPACE (2015)
Changes in Renal Function in Patients With Atrial Fibrillation An Analysis From the RE-LY Trial
Michael Boehm et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis
Daniel Caldeira et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats
Margaret Ryan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
Lars Wallentin et al.
CIRCULATION (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
5/6 Nephrectomy as a Validated Rat Model Mimicking Human Warfarin-Related Nephropathy
A. Ozcan et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Vascular calcification: The price to pay for anticoagulation therapy with vitamin K-antagonists
Martijn L. L. Chatrou et al.
BLOOD REVIEWS (2012)
Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque Phenotype
Leon J. Schurgers et al.
PLOS ONE (2012)
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate
Sergey V. Brodsky et al.
KIDNEY INTERNATIONAL (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Negative Controls A Tool for Detecting Confounding and Bias in Observational Studies
Marc Lipsitch et al.
EPIDEMIOLOGY (2010)
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Lars Wallentin et al.
LANCET (2010)
Acute Kidney Injury During Warfarin Therapy Associated With Obstructive Tubular Red Blood Cell Casts: A Report of 9 Cases
Sergey V. Brodsky et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Patient Awareness of Chronic Kidney Disease Trends and Predictors
Laura C. Plantinga et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Observational research, randomised trials, and two views of medical science
Jan P. Vandenbroucke
PLOS MEDICINE (2008)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Adjusted survival curves with inverse probability weights
SR Cole et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Share Paper
